These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies: results of a multicenter, prospective, open-label study of twenty-two patients. Martinez V; Cohen P; Pagnoux C; Vinzio S; Mahr A; Mouthon L; Sailler L; Delaunay C; Sadoun A; Guillevin L; Arthritis Rheum; 2008 Jan; 58(1):308-17. PubMed ID: 18163506 [TBL] [Abstract][Full Text] [Related]
23. Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis. Keogh KA; Wylam ME; Stone JH; Specks U Arthritis Rheum; 2005 Jan; 52(1):262-8. PubMed ID: 15641078 [TBL] [Abstract][Full Text] [Related]
24. Serum concentration of interleukin-18 is up-regulated in patients with ANCA-associated vasculitis. Hultgren O; Andersson B; Hahn-Zoric M; Almroth G Autoimmunity; 2007 Nov; 40(7):529-31. PubMed ID: 17966043 [TBL] [Abstract][Full Text] [Related]
25. Cytapheresis for the treatment of myeloperoxidase antineutrophil cytoplasmic autoantibody-associated vasculitis: a pilot study of 21 patients. Hasegawa M; Ohashi A; Kabutan N; Hiramatsu S; Kato M; Murakami K; Tomita M; Nabeshima K; Hiki Y; Sugiyama S Ther Apher Dial; 2006 Oct; 10(5):412-8. PubMed ID: 17096695 [TBL] [Abstract][Full Text] [Related]
26. Propylthiouracil-associated antineutrophil cytoplasmic autoantibody-positive vasculitis: retrospective study of 19 cases. Chen YX; Yu HJ; Ni LY; Zhang W; Xu YW; Ren H; Chen XN; Wang XL; Li X; Pan XX; Wang WM; Chen N J Rheumatol; 2007 Dec; 34(12):2451-6. PubMed ID: 17985400 [TBL] [Abstract][Full Text] [Related]
27. Increased serum levels of soluble triggering receptor expressed on myeloid cells-1 in antineutrophil cytoplasmic antibody-associated vasculitis. Daikeler T; Regenass S; Tyndall A; Gencay MM; Roth M; Christ-Crain M; Müller B; Hess C Ann Rheum Dis; 2008 May; 67(5):723-4. PubMed ID: 18408110 [No Abstract] [Full Text] [Related]
28. New strategies in the treatment of systemic vasculitis. Jayne DR; Lockwood CM Ann Med Interne (Paris); 1994; 145(8):595-600. PubMed ID: 7710186 [No Abstract] [Full Text] [Related]
30. Further characterization of an animal model of systemic vasculitis. Qasim FJ; Mathieson PW; Thiru S; Oliveira DB; Lockwood CM Adv Exp Med Biol; 1993; 336():133-7. PubMed ID: 8296602 [TBL] [Abstract][Full Text] [Related]
31. [Diagnosis and therapy for vasculitis]. Ozaki S Nihon Naika Gakkai Zasshi; 2007 Oct; 96(10):2177-88. PubMed ID: 18044153 [No Abstract] [Full Text] [Related]
33. ANCA +ve vasculitis after autologous PBSC transplantation. Kingdon EJ; Johnston RE; Pawson R; Prentice HG; Potter MN; Burns A; Powis SH Nephrol Dial Transplant; 2002 Feb; 17(2):285-7. PubMed ID: 11812882 [No Abstract] [Full Text] [Related]
34. ANCA glomerulonephritis and vasculitis: a Chapel Hill perspective. Falk RJ; Nachman PH; Hogan SL; Jennette JC Semin Nephrol; 2000 May; 20(3):233-43. PubMed ID: 10855933 [TBL] [Abstract][Full Text] [Related]
35. Clinical outcome of patients with coexistent antineutrophil cytoplasmic antibodies and antibodies against glomerular basement membrane. Lindic J; Vizjak A; Ferluga D; Kovac D; Ales A; Kveder R; Ponikvar R; Bren A Ther Apher Dial; 2009 Aug; 13(4):278-81. PubMed ID: 19695059 [TBL] [Abstract][Full Text] [Related]
36. New treatment strategies for systemic vasculitis: the role of intravenous immune globulin therapy. Lockwood CM Clin Exp Immunol; 1996 May; 104 Suppl 1():77-82. PubMed ID: 8625549 [TBL] [Abstract][Full Text] [Related]
37. [Therapeutic effect and clinical findings in patients with MPO-ANCA associated vasculitis syndrome]. Yoshida A; Takeda A; Fukuda M; Toda S; Morozumi K Ryumachi; 2000 Feb; 40(1):1-8. PubMed ID: 10783659 [TBL] [Abstract][Full Text] [Related]
38. New insight into the pathogenesis of vasculitis associated with antineutrophil cytoplasmic autoantibodies. Jennette JC; Falk RJ Curr Opin Rheumatol; 2008 Jan; 20(1):55-60. PubMed ID: 18281858 [TBL] [Abstract][Full Text] [Related]
39. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. De Groot K; Rasmussen N; Bacon PA; Tervaert JW; Feighery C; Gregorini G; Gross WL; Luqmani R; Jayne DR Arthritis Rheum; 2005 Aug; 52(8):2461-9. PubMed ID: 16052573 [TBL] [Abstract][Full Text] [Related]
40. The target antigens of antineutrophil cytoplasmic antibodies (ANCA) induced by propylthiouracil. Gao Y; Chen M; Ye H; Guo XH; Zhao MH; Wang HY Int Immunopharmacol; 2007 Jan; 7(1):55-60. PubMed ID: 17161817 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]